Elfego Hernán Monzón Aguirre

Recent publications · Crossref

5 total works indexed

1. RoB 2: a revised tool for assessing risk of bias in randomised trials

   · 2019 · cited 23,882x

2. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

   · 2016 · cited 14,665x

3. The GTEx Consortium atlas of genetic regulatory effects across human tissues

   · 2020 · cited 5,059x

4. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

   · 2016 · cited 4,396x

5. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

   · 2012 · cited 4,393x

via Crossref · CC0